| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-51,059 | -42,468 | |||||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||
Stock-based compensation expense | ||||||
3,836 | 502 | |||||
Depreciation and amortization | ||||||
3,078 | 2,167 | |||||
Provision for bad debts | ||||||
104 | 273 | |||||
Loss on disposal of property and equipment | ||||||
-101 | -511 | |||||
Amortization of discount on debt | ||||||
234 | 123 | |||||
Loss on extinguishment of debt | ||||||
- | -2,842 | |||||
Gain on litigation settlement | ||||||
1,151 | - | |||||
Deferred income taxes | ||||||
-147 | - | |||||
Change in fair value of warrants | ||||||
- | -553 | |||||
Changes in operating assets and liabilities, net of acquisition: | ||||||
Accounts receivable | ||||||
833 | 425 | |||||
Inventories | ||||||
-5,063 | 2,252 | |||||
Prepaid expenses and other assets | ||||||
1,218 | 443 | |||||
Accounts payable | ||||||
98 | 896 | |||||
Contract liabilities | ||||||
58 | 15 | |||||
Accrued expenses and other current liabilities | ||||||
2,174 | -1,206 | |||||
Net cash used in operating activities | ||||||
-39,662 | -40,018 | |||||
Cash flows from investing activities | ||||||
Purchases of property and equipment | ||||||
4,747 | 5,180 | |||||
Acquisition of business, net of cash acquired | ||||||
1,560 | - | |||||
Net cash used in investing activities | ||||||
-6,307 | -5,180 | |||||
Cash flows from financing activities | ||||||
Short-term line of credit | ||||||
316 | 136 | |||||
Proceeds from issuance of common stock in connection with public offering, net | ||||||
48,669 | 59,892 | |||||
Proceeds on loans | ||||||
10,500 | 32,000 | |||||
Proceeds from issuance of redeemable convertible preferred stock, net | ||||||
- | 9,919 | |||||
Repayment of loans payable | ||||||
- | 22,328 | |||||
Public offering costs | ||||||
393 | 2,498 | |||||
Debt issuance costs | ||||||
29 | 800 | |||||
Proceeds from exercise of stock options and purchase of restricted stock | ||||||
386 | 539 | |||||
Net cash provided by financing activities | ||||||
59,449 | 76,860 | |||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
5 | - | |||||
Net decrease in cash, cash equivalents and restricted cash | ||||||
13,485 | 31,662 | |||||
Supplemental disclosures of cash flow information | ||||||
Interest paid during the period | ||||||
4,793 | 3,028 | |||||
Property and equipment purchases in accounts payable and accrued expenses | ||||||
135 | 21 | |||||
Issuance of common stock upon vesting of restricted stock | ||||||
402 | 360 | |||||
Issuance of warrants in conjunction with debt draw down | ||||||
293 | - | |||||
Conversion of preferred stock to common stock | ||||||
- | 162,637 | |||||